← Leaderboards
Erik R Dubberke
Washington University
$2,686,761
Attributed
$5,617,014
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,617,014 · 5
By mechanism
U01$3,101,938 · 1
R01$1,491,338 · 1
R21$649,350 · 2
K23$374,388 · 1
Top collaborators
- Gautam Dantas3 shared
- Sarah Kelly Mcgill2 shared
- David M Aronoff1 shared
- Ryan S Doster1 shared
Most similar at Washington University
Same institution · by research overlap
- Marshall Alan Permutt$16,076,220
- Timothy J Eberlein$71,591,509
- Gautam Dantas$16,547,812
- David A Harris$28,262,949
- Ana Lidia Flores-Mireles$1,343,189
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPreventClostridium DifficileTransmission ProcessCostPreventionPathogenAntibiotic ResistancePathogenesisMorbidity - Disease RateInnovationToxinPatient PopulationDesignHigh RiskResearch ProposalsHospitalsHealthcareEpidemiologyAntibioticsResearch DesignDiarrheaNosocomial InfectionsAntimicrobial
Grant awards (10)
High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection$745,133
R01 · FY2025 · AI
Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infection$233,250
R21 · FY2025 · AI · contact PI
High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection$746,205
R01 · FY2024 · AI
Repurposing misoprostol to prevent recurrence of Clostridium difficile infection$1,550,850
U01 · FY2019 · TR
Repurposing misoprostol to prevent recurrence of Clostridium difficile infection$1,551,088
U01 · FY2018 · TR
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTS$124,462
K23 · FY2011 · AI · contact PI
VALIDATION AND MODELING OF A C. DIFFICILE INFECTION RISK PREDICTION INDEX$188,100
R21 · FY2010 · NR · contact PI
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTS$125,028
K23 · FY2010 · AI · contact PI
VALIDATION AND MODELING OF A C. DIFFICILE INFECTION RISK PREDICTION INDEX$228,000
R21 · FY2009 · NR · contact PI
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTS$124,898
K23 · FY2009 · AI · contact PI